Not investment advice. Educational platform. See Disclaimer.
NASDAQ: DMRA
Galecto, Inc.
Healthcare | Biotechnology
No licensed closing price on file for DMRA. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
Galecto, Inc. (NASDAQ: DMRA) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 07:14 UTC.
2026-05-04Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2026-03-23Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2024-10-07Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersWinslow's Retention Bonus AgreementAuthoritativeSEC 8-K →